Zevra Therapeutics (ZVRA) Operating Leases (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Operating Leases of $1.1 million for Q1 2026, up 33.53% on a QoQ basis from $859000.0 in Q4 2025, and down 0.95% year-over-year from $1.2 million in Q1 2025.
Zevra Therapeutics (ZVRA) Operating Leases (2019 - 2026) Analysis & Trends
Zevra Therapeutics' Operating Leases history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Operating Leases fell 0.95% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 0.95% YoY) and the FY2025 annual result came in at $859000.0, up 8.46% from the prior year.
- Operating Leases was $1.1 million for Q1 2026 at Zevra Therapeutics, up from $859000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.6 million in Q2 2025 and bottomed at $456000.0 in Q4 2023.
- A 5-year average of $941153.8 and a median of $859000.0 in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases tumbled 46.91% — and 2025, when it surged 191.3%.
- Zevra Therapeutics' Operating Leases stood at $843000.0 in 2022, then plunged by 45.91% to $456000.0 in 2023, then jumped by 73.68% to $792000.0 in 2024, then climbed by 8.46% to $859000.0 in 2025, then soared by 33.53% to $1.1 million in 2026.
- Business Quant data shows ZVRA's Operating Leases at $1.1 million in Q1 2026, $859000.0 in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 859,000.00 |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 792,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 705,000.00 |
| Dec 31, 2023 | 456,000.00 |
| Sep 30, 2023 | 517,000.00 |
| Dec 31, 2022 | 843,000.00 |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 1.67 Mn |
| Jun 30, 2021 | 1.41 Mn |
| Mar 31, 2021 | 1.50 Mn |
| Dec 31, 2020 | 1.59 Mn |
| Sep 30, 2020 | 1.99 Mn |
| Jun 30, 2020 | 2.06 Mn |